Éloi R. Verrier

1.4k total citations
46 papers, 748 citations indexed

About

Éloi R. Verrier is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Éloi R. Verrier has authored 46 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 29 papers in Hepatology and 9 papers in Infectious Diseases. Recurrent topics in Éloi R. Verrier's work include Hepatitis B Virus Studies (31 papers), Hepatitis C virus research (28 papers) and Liver Disease Diagnosis and Treatment (15 papers). Éloi R. Verrier is often cited by papers focused on Hepatitis B Virus Studies (31 papers), Hepatitis C virus research (28 papers) and Liver Disease Diagnosis and Treatment (15 papers). Éloi R. Verrier collaborates with scholars based in France, Germany and United States. Éloi R. Verrier's co-authors include Thomas F. Baumert, Christelle Langevin, Pierre Boudinot, Che C. Colpitts, Catherine Schuster, Abdenour Benmansour, Mirjam B. Zeisel, Gaëtan Ligat, Thomas F. Baumert and Laura Heydmann and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Virology.

In The Last Decade

Éloi R. Verrier

39 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Éloi R. Verrier France 17 386 308 272 162 148 46 748
Auda A. Eltahla Australia 15 199 0.5× 240 0.8× 247 0.9× 223 1.4× 239 1.6× 25 752
Andrea K. Erickson United States 11 225 0.6× 229 0.7× 288 1.1× 228 1.4× 177 1.2× 14 733
Stefan Seitz Germany 13 641 1.7× 517 1.7× 170 0.6× 173 1.1× 165 1.1× 30 952
Zohreh Sharifi Iran 15 410 1.1× 218 0.7× 144 0.5× 132 0.8× 159 1.1× 130 844
James H. McLinden United States 19 299 0.8× 364 1.2× 127 0.5× 170 1.0× 173 1.2× 39 781
Fabien Abdul France 8 386 1.0× 225 0.7× 78 0.3× 126 0.8× 252 1.7× 10 590
Rodrigo A. Villanueva Chile 13 399 1.0× 425 1.4× 91 0.3× 96 0.6× 188 1.3× 30 675
Sangeetha Vijaysri United States 7 341 0.9× 278 0.9× 194 0.7× 86 0.5× 178 1.2× 7 657
Lise Rivière France 14 546 1.4× 317 1.0× 258 0.9× 211 1.3× 298 2.0× 15 907
Zhipeng Yan China 21 562 1.5× 124 0.4× 413 1.5× 330 2.0× 305 2.1× 35 1.1k

Countries citing papers authored by Éloi R. Verrier

Since Specialization
Citations

This map shows the geographic impact of Éloi R. Verrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éloi R. Verrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éloi R. Verrier more than expected).

Fields of papers citing papers by Éloi R. Verrier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éloi R. Verrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éloi R. Verrier. The network helps show where Éloi R. Verrier may publish in the future.

Co-authorship network of co-authors of Éloi R. Verrier

This figure shows the co-authorship network connecting the top 25 collaborators of Éloi R. Verrier. A scholar is included among the top collaborators of Éloi R. Verrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éloi R. Verrier. Éloi R. Verrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Heydmann, Laura, C Bach, Sarah Durand, et al.. (2025). Hepatitis B virus-infected hepatocytes promote the secretion of collagen VI to the extracellular matrix. Scientific Reports. 15(1). 24949–24949.
3.
Verrier, Éloi R., et al.. (2025). Hijacking JAKis: JAK inhibitors as potential antiviral molecules, a mini review. Antiviral Research. 237. 106153–106153.
4.
Campbell, James, Éloi R. Verrier, Motswedi Anderson, et al.. (2025). Clinical trials for Hepatitis Delta Virus in the WHO African region: A neglected virus among neglected viruses. Journal of Infection. 91(1). 106514–106514. 1 indexed citations
5.
Tu, Thomas, Jochen M. Wettengel, Yuchen Xia, et al.. (2024). Major open questions in the hepatitis B and D field – Proceedings of the inaugural International emerging hepatitis B and hepatitis D researchers workshop. Virology. 595. 110089–110089. 1 indexed citations
6.
Bach, C, Emanuele Felli, Fabio Giannone, et al.. (2023). JAK1 promotes HDV replication and is a potential target for antiviral therapy. Journal of Hepatology. 80(2). 220–231. 9 indexed citations
7.
Vanrusselt, Hannah, Dieudonné Buh Kum, Valério Taverniti, et al.. (2023). Novel non-HAP class A HBV capsid assembly modulators have distinct in vitro and in vivo profiles. Journal of Virology. 97(10). e0072223–e0072223. 4 indexed citations
8.
Rybicka, Magda, Éloi R. Verrier, Thomas F. Baumert, & Krzysztof Piotr Bielawski. (2023). Polymorphisms within DIO2 and GADD45A genes increase the risk of liver disease progression in chronic hepatitis b carriers. Scientific Reports. 13(1). 6124–6124.
9.
Verrier, Éloi R., Anna Salvetti, Caroline Pons, et al.. (2022). Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method. univOAK (4 institutions : Université de Strasbourg, Université de Haute Alsace, INSA Strasbourg, Bibliothèque Nationale et Universitaire de Strasbourg). 12 indexed citations
10.
Saviano, Antonio, Clara Ponsolles, Laura Heydmann, et al.. (2021). Hepatitis B virus compartmentalization and single-cell differentiation in hepatocellular carcinoma. Life Science Alliance. 4(9). e202101036–e202101036. 7 indexed citations
11.
Baumert, Thomas F., et al.. (2021). Cell Culture Models for the Study of Hepatitis D Virus Entry and Infection. Viruses. 13(8). 1532–1532. 9 indexed citations
12.
Verrier, Éloi R.. (2021). Jet virology: analysis of scientific publications during pandemics. Virologie. 25(3). 137–139.
13.
Ligat, Gaëtan, Éloi R. Verrier, Michael Nassal, & Thomas F. Baumert. (2021). Hepatitis B virus–host interactions and novel targets for viral cure. Current Opinion in Virology. 49. 41–51. 27 indexed citations
14.
Saviano, Antonio, et al.. (2020). Targeting the Host for New Therapeutic Perspectives in Hepatitis D. Journal of Clinical Medicine. 9(1). 222–222. 14 indexed citations
15.
Wang, Shizhi, Dénis Laloë, Thomas Lewis, et al.. (2018). Breeding policies and management of pedigree dogs in 15 national kennel clubs. The Veterinary Journal. 234. 130–135. 6 indexed citations
16.
Verrier, Éloi R., Amélie Weiss, C Bach, et al.. (2018). XXes Journ�es francophones de virologie. Virologie. 22(2). 115–117.
17.
Verrier, Éloi R., Che C. Colpitts, C Bach, et al.. (2016). Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes. Cell Reports. 17(5). 1357–1368. 35 indexed citations
18.
Verrier, Éloi R., M. Dorson, Stéphane Mauger, et al.. (2013). Resistance to a Rhabdovirus (VHSV) in Rainbow Trout: Identification of a Major QTL Related to Innate Mechanisms. PLoS ONE. 8(2). e55302–e55302. 36 indexed citations
19.
Verrier, Éloi R., Christelle Langevin, Abdenour Benmansour, & Pierre Boudinot. (2011). Early antiviral response and virus-induced genes in fish. Developmental & Comparative Immunology. 35(12). 1204–1214. 98 indexed citations
20.
Khang, J. Vu Tien, et al.. (1994). Bilan génétique des programmes de conservation des races ovines Solognote et Mérinos précoce. Genetics Selection Evolution. 26(S1). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Auda A. Eltahla Breakdown of academic impact, for papers by Andrea K. Erickson Breakdown of academic impact, for papers by Stefan Seitz Breakdown of academic impact, for papers by Zohreh Sharifi Breakdown of academic impact, for papers by James H. McLinden Breakdown of academic impact, for papers by Fabien Abdul Breakdown of academic impact, for papers by Rodrigo A. Villanueva Breakdown of academic impact, for papers by Sangeetha Vijaysri Breakdown of academic impact, for papers by Lise Rivière Breakdown of academic impact, for papers by Zhipeng Yan
Rankless by CCL
2026